These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 18322775)

  • 21. Osteomyelitis and septic arthritis after Mycobacterium Bovis BCG Therapy for Urinary Bladder Cancer.
    Lee SC; Geannette CS
    Clin Imaging; 2020 Dec; 68():179-183. PubMed ID: 32841934
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Back pain following instillations of BCG for superficial bladder cancer is not a reactive complication: review of 30 Mycobacterium bovis BCG vertebral osteomyelitis cases.
    Cadiou S; Al Tabaa O; Nguyen CD; Faccin M; Guillin R; Revest M; Guggenbuhl P; Houvenagel E; Pertuiset E; Coiffier G
    Clin Rheumatol; 2019 Jun; 38(6):1773-1783. PubMed ID: 30868320
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mycobacterium bovis infection of an aortobifemoral bypass graft with Streptococcus intermedius superinfection after intravesical bacillus Calmette-Guérin immunotherapy for bladder cancer.
    Dubert M; Abihssira S; Diamantis S; Guenin R; Messaoudi R; Roux AL; Rouis K; Lillo A; Surgers L; Douard R; Julia P; Lebeaux D
    Infection; 2021 Apr; 49(2):345-348. PubMed ID: 32749595
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reiter's syndrome postintravesical Bacillus Calmette-Guérin instillations.
    Ng KL; Chua CB
    Asian J Surg; 2017 Apr; 40(2):163-165. PubMed ID: 25183290
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mycotic aneurysm of the aorta as a complication of Bacillus Calmette-Guérin instillation.
    Maundrell J; Fletcher S; Roberts P; Stein A; Lambie M
    J R Coll Physicians Edinb; 2011 Jun; 41(2):114-6. PubMed ID: 21677913
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Disseminated BCG infection in patients with urinary bladder carcinoma].
    Korać M; Milosević B; Lavadinović L; Janjić A; Brmbolić B
    Med Pregl; 2009; 62(11-12):592-5. PubMed ID: 20491388
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A report of iliac muscle abscess due to Mycobacterium bovis after bacillus Calmette-Guerin therapy for bladder cancer.
    Talluri SK; Marigowda L; Besur S; Talluri J; Forstall GJ
    South Med J; 2010 Apr; 103(4):369-70. PubMed ID: 20224496
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mycobacterium bovis Infection of a Deep Brain Stimulation System Following Intravesical Bacillus Calmette-Guérin (BCG) Instillation.
    Spruijt LE; Mosch A; Hoffmann CFE; van Nieuwkoop C; Tijsterman JD; Zutt R; van der Gaag NA; Contarino MF
    J Parkinsons Dis; 2024; 14(5):1061-1069. PubMed ID: 38788088
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mycobacterium bovis osteomyelitis as a complication of Bacille Calmette-Guérin (BCG) vaccination: rapid diagnosis with use of DNA sequencing analysis: a case report.
    Lin CJ; Yang WS; Yan JJ; Liu CC
    J Bone Joint Surg Am; 1999 Sep; 81(9):1305-11. PubMed ID: 10505527
    [No Abstract]   [Full Text] [Related]  

  • 30. Bacillus Calmette-Guérin-induced granulomatous hepatitis in a patient with a superficial bladder carcinoma.
    Van Outryve SM; Francque SM; Gentens PA; De Pauw FF; Van den Bogaert E; Van Marck EA; Pelckmans PA; Michielsen PP
    Eur J Gastroenterol Hepatol; 2004 Oct; 16(10):1027-32. PubMed ID: 15371927
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Granulomatous hepatitis revealing a Mycobacterium bovis widespread infection following intravesical BCG therapy].
    Raffray L; Rivière P; Bonnet H; Duffau P; Longy-Boursier M
    Rev Med Interne; 2015 Sep; 36(9):626-30. PubMed ID: 25467298
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mycobacteremia and granulomatous hepatitis following initial intravesical bacillus Calmette-Guerin instillation for bladder carcinoma.
    Proctor DD; Chopra S; Rubenstein SC; Jokela JA; Uhl L
    Am J Gastroenterol; 1993 Jul; 88(7):1112-5. PubMed ID: 8317415
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Granulomatous hepatitis after intravesical BCG treatment for bladder cancer.
    Ersoy O; Aran R; Aydinli M; Yonem O; Harmanci O; Akdogan B; Pinar A; Sokmensuer C; Bayraktar Y
    Indian J Gastroenterol; 2006; 25(5):258-9. PubMed ID: 17090848
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Prophylactic effect of inductive intravesical instillation of Bacillus Calmette-Guerin on postoperative recurrence of bladder cancer].
    Yi SH; Ye G; Wang XW; Jin HS; Zhang YN; Yan ZL
    Ai Zheng; 2008 Nov; 27(11):1208-11. PubMed ID: 19000455
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chorioretinitis induced by intravesical Bacillus Calmette-Guérin (BCG) instillations for urinary bladder carcinoma.
    Guex-Crosier Y; Chamot L; Zografos L
    Klin Monbl Augenheilkd; 2003 Mar; 220(3):193-5. PubMed ID: 12664378
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systemic bacillus Calmette-Guerin infection in patients treated by intravesical BCG therapy for superficial bladder cancer.
    Steg A; Leleu C; Debré B; Boccon-Gibod L; Sicard D
    Prog Clin Biol Res; 1989; 310():325-34. PubMed ID: 2672020
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mycobacterium bovis BCG causing vertebral osteomyelitis (Pott's disease) following intravesical BCG therapy.
    Aljada IS; Crane JK; Corriere N; Wagle DG; Amsterdam D
    J Clin Microbiol; 1999 Jun; 37(6):2106-8. PubMed ID: 10325395
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bacillus Calmette-Guérin (BCG) infection following intravesical BCG administration as adjunctive therapy for bladder cancer: incidence, risk factors, and outcome in a single-institution series and review of the literature.
    Pérez-Jacoiste Asín MA; Fernández-Ruiz M; López-Medrano F; Lumbreras C; Tejido Á; San Juan R; Arrebola-Pajares A; Lizasoain M; Prieto S; Aguado JM
    Medicine (Baltimore); 2014 Oct; 93(17):236-254. PubMed ID: 25398060
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mycobacterium bovis osteomyelitis involving a hip arthroplasty after intravesicular bacille Calmette-Guérin for bladder cancer.
    Guerra CE; Betts RF; O'Keefe RJ; Shilling JW
    Clin Infect Dis; 1998 Sep; 27(3):639-40. PubMed ID: 9770167
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A case of disseminated Mycobacterium bovis 2 years post-intravesicular Bacillus Calmette-Guérin therapy for superficial urinary bladder cancer.
    Robinson ARL; Radhakrishnan R; Horvath R; Pandey S
    Intern Med J; 2017 Jul; 47(7):820-823. PubMed ID: 28677313
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.